Free Trial
NYSEAMERICAN:CCEL

Cryo-Cell International 10/15/2024 Earnings Report

Cryo-Cell International logo
$5.62 -0.11 (-1.92%)
Closing price 04/25/2025 04:10 PM Eastern
Extended Trading
$5.61 -0.01 (-0.16%)
As of 04/25/2025 06:00 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Cryo-Cell International EPS Results

Actual EPS
$0.13
Consensus EPS
$0.02
Beat/Miss
Beat by +$0.11
One Year Ago EPS
N/A

Cryo-Cell International Revenue Results

Actual Revenue
$8.07 million
Expected Revenue
N/A
Beat/Miss
N/A
YoY Revenue Growth
N/A

Cryo-Cell International Announcement Details

Quarter
Time
TAS
Conference Call Date
N/A
Conference Call Time
N/A

Conference Call Resources

Cryo-Cell International Earnings Headlines

Cryo-Cell price target lowered to $8.50 from $9 at Maxim
$2 Trillion Disappears Because of Fed's Secretive New Move
$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being carried out by the Fed that has nothing to do with lowering or raising interest rates... but could soon have an enormous impact on your wealth.
Cryo-Cell reports FY24 EPS 5c vs ($1.14) last year
See More Cryo-Cell International Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Cryo-Cell International? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Cryo-Cell International and other key companies, straight to your email.

About Cryo-Cell International

Cryo-Cell International (NYSEAMERICAN:CCEL) engages in the cellular processing and cryogenic cellular storage with a focus on the collection and preservation of umbilical cord blood stem cells for family use. It provides cord tissue service that stores a section of the umbilical cord tissue, a source of mesenchymal stem cells that are used in regenerative medicine to treat a range of conditions, including heart, and kidney disease, ALS, wound healing, auto-immune diseases, multiple sclerosis, Alzheimer's disease, Parkinson's diseases. The company manufactures and sells PrepaCyte CB processing system, a technology used to process umbilical cord blood stem cells. It markets its cord blood stem cell preservation services directly to expectant parents, as well as by distributing information through obstetricians, pediatricians, childbirth educators, certified nurse-midwives, and other related healthcare professionals. Cryo-Cell International, Inc. was incorporated in 1989 and is headquartered in Oldsmar, Florida.

View Cryo-Cell International Profile

More Earnings Resources from MarketBeat